FIELD: medicine.
SUBSTANCE: predicting heart rhythm disorder in the patients with pre-excitation syndromes is ensured by measuring patient's blood plasma matrix metalloproteinase-9 (MMP-9), and if the measured value is less than 90.6 ng/ml, the favourable clinical course accompanied by no heart rhythm disorders (HRD) is predicted, whereas the MMP-9 concentration of more than 90.6 ng/ml enables predicting HRD.
EFFECT: method enables predicting HRD in the patients with pre-excitation syndromes by high sensitivity and specificity of the method with its low invasiveness and no counterindications.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF HEART RHYTHM DISORDERS IN PATIENTS SUFFERING VENTRICULAR PREEXCITATION SYNDROME | 2014 |
|
RU2560670C1 |
| METHOD FOR PHARMACOLOGICAL AUTONOMIC HEART BLOCK | 2014 |
|
RU2572339C1 |
| METHOD OF PREDICTING DEVELOPMENT OF CRITICAL STENOSIS OF CORONARY ARTERIES IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2014 |
|
RU2550947C1 |
| METHOD OF DIAGNOSING PAROXYSMAL TACHYCARDIA | 2009 |
|
RU2411902C1 |
| PHARMACEUTICAL COMPOSITION PREVENTING DEVELOPMENT OF PREEXCITATION SYNDROME | 2011 |
|
RU2453313C1 |
| METHOD FOR PREDICTION OF DEVELOPING LIFE-THREATENING VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH NO STRUCTURAL CARDIAC CHANGES | 2011 |
|
RU2456019C1 |
| METHOD OF DIAGNOSING LEFT-SIDED LOCALISATION OF ADDITIONAL ATRIOVENTRICULAR CONNECTIONS IN CHILDREN WITH WOLFF-PARKINSON-WHITE SYNDROME | 2011 |
|
RU2471410C1 |
| METHOD FOR TREATING PATIENTS FOR PAROXYSMAL RECIPROCAL TACHICARDIA ON THE BACKGROUND OF WPW SYNDROME | 1999 |
|
RU2195983C2 |
| METHOD OF IMMUNOLOGICAL PREDICTION OF SUDDEN CORONARY DEATH | 2023 |
|
RU2810015C1 |
| METHOD FOR CLINICAL ASSESSMENT OF PROBABILITY NON-MASSIVE PULMONARY ARTERY THROMBOEMBOLIA IN PATIENTS RECEIVING MENOPAUSAL HORMONE THERAPY | 2015 |
|
RU2596056C1 |
